VRAX Competitors & Alternatives
Compare Virax Biolabs Group Limited Ordinary Shares with similar stocks in the same industry
In Vitro & In Vivo Diagnostic Substances
VRAX
Main Stock$0.16
Tradestie Score
44
Market Cap
$2.69M
Revenue Growth
-0.7%
Analyst Upside
+1745.6%
Top Competitors
19 stocks in In Vitro & In Vivo Diagnostic Substances| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IDXX
Idexx Laboratories Inc
|
$558.12
|
$49.61B | 43.9 | 59 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$72.97
|
$3.51B | 22.4 | 55 | Compare |
|
QDEL
QuidelOrtho Corporation Common Stock
|
$15.25
|
$2.12B | - | 51 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.71
|
$2.01B | - | 52 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$29.43
|
$1.68B | - | 46 | Compare |
|
NNNN
Anbio Biotechnology Class A Ordinary Shares
|
$23.60
|
$1.53B | 386.7 | 56 | Compare |
|
NEOG
Neogen Corp
|
$8.83
|
$1.26B | - | 52 | Compare |
|
MYGN
Myriad Genetics Inc
|
$4.31
|
$719.23M | - | 52 | Compare |
|
TKNO
Alpha Teknova, Inc. Common Stock
|
$2.66
|
$340.89M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$2.68
|
$158.43M | - | 48 | Compare |
More VRAX Analysis
Data updated: Mar 30, 2026 | Industry: In Vitro & In Vivo Diagnostic Substances (SIC 2835)
19 stocks in this industry